KYLIE WITHAM: Open Payments
NPI 1316019458 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,716 in 79 payments from 15 companies in 2025. Trend: 2023 $526 · 2024 $833 · 2025 $1,716
Food & beverage: $1,716
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 10 | $361 |
| Janssen Biotech, Inc. | 11 | $244 |
| ABBVIE INC. | 13 | $222 |
| E.R. Squibb & Sons, L.L.C. | 18 | $210 |
| Novartis Pharmaceuticals Corporation | 4 | $188 |
| UCB, Inc. | 5 | $120 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
| Arcutis Biotherapeutics, Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $60 |
| Organon LLC | 3 | $49 |
Products named: NEMLUVIO, TREMFYA, Sotyktu, RINVOQ, Bimzelx, Rhapsido, DUPIXENT, SKYRIZI.
Industry payments across KS — which companies pay providers there.
